Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in Korea

Clinical trial NCT02555761 · COMPLETED

Trial details

NCT number: NCT02555761
Sponsor: Allergan
Status: COMPLETED
Study type: OBSERVATIONAL

Conjunctivitis, Allergic

Start date: 2015-10-19
Primary completion: 2018-03-19
Enrollment: 3423

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.